BioLaunch Course: Clearing the Way: What you should know when starting a company
Speaker: Gabriele Niederauer
This event is brought to you in partnership with Bluegrass Vascular.
April 28th, 2022
11:30 a.m. – 12 p.m. CST | Networking (In-Person Attendees only)
12 – 1 p.m. C ST | Course Presentation and Q&A
Every startup and founder will have a different journey, but learning from those who succeed will help companies pave a more robust path to commercialization. Hear a CEO’s story on how Bluegrass Vascular Technologies has achieved its success to date with a first-time CEO at the helm. The realities of launching a medical device, success stories, and learning opportunities.
Topics to be covered:
- The journey to now
- Excelling with a lean team
- Navigating the FDA submission process
- Adapting when reimbursements don’t go as hoped
- What it took as a founder to get the job done
- How you can use other’s success as guidance
- Think innovatively and adapt quickly
- Support systems available (ex. Mentors, resources, …)
- What it looks like to launch a medical device with a small team
In-Person | $20 with Lunch Included | Registration closes on April 26th
(VelocityTX Incubator members please contact McKenna@velocitytx.org for the discount code.)
Virtual | $10
Zoom information will be posted on the day of the event and sent via Eventbrite email.
Free onsite parking available (1304 E Houston St, San Antonio, TX 78205). Download parking instructions.
About the Speaker:
Gabriele Niederauer, CEO & President
Gabriele Niederauer is an accomplished and highly-engaged Chief Executive Officer of a private, commercial-stage, medical device company with broad-based experience taking clinical ideas from concept to market. She is a servant leader with a high priority on building a successful enterprise, deepening physician relationships, and growing market presence and sales. Developed through experience, her strong technical and communication skills are known for creating compelling and influential presentations and public speaking.